You are here

  • Home
  • Archive
  • Volume 16, Issue 4
  • Varenicline increases smoking abstinence at 6 months to a year compared with placebo or bupropion; nausea is the most commonly reported adverse effect

Article Text

Article menu
Download PDFPDF
Therapeutics
Systematic review
Varenicline increases smoking abstinence at 6 months to a year compared with placebo or bupropion; nausea is the most commonly reported adverse effect

https://doi.org/10.1136/ebm1200

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests MEM has received unrestricted research grants, including salary support, from Pfizer. MS and DD have no conflicting interests.